MedPath

Anti-fatigue effect of Caffeine-Q10 supplementatio

Not Applicable
Conditions
Exercise-induced physiological stress.
Drug or medicament, unspecified
Registration Number
IRCT201305124663N13
Lead Sponsor
niversity of Tabriz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
32
Inclusion Criteria

Inclusion: Female; 20-28 year; healthy; Aerobics athletes; BMI <25; without any anti-inflammatory or medical drug such as caffeine >100 mg/day
(during 6 months prior to the study)
Exclusion: Diseases; Injuries; Uncontrolled intake of anti-inflammatory drugs during the period; Uncontrolled intake of stimulants during the period;

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total Serum Cereatine kinase (CK). Timepoint: 30 minutes before first Aerobics session; 30 minutes before last Aerobics session; and 18- 24 hours after supplementation and training protocol. Method of measurement: photometric methods with commercial kits (Bionik kit).;Lactate Dehydrogenase. Timepoint: 30 minutes before first Aerobics session; 30 minutes before last Aerobics session; and 18- 24 hours after supplementation and training protocol. Method of measurement: photometric methods with commercial kits (Bionik kit).;Capillary Lactate. Timepoint: Before first and last session and after last session. Method of measurement: Scot lactometer.
Secondary Outcome Measures
NameTimeMethod
Blood Presure. Timepoint: 30 minutes before every trainig session. Method of measurement: Aneroid blood pressure measurement.;Body Temperature. Timepoint: 30 minutes before every training session. Method of measurement: Thermometer.
© Copyright 2025. All Rights Reserved by MedPath